Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/49441
Title: Capsule Size Alters the Timing of Metabolic Alkalosis Following Sodium Bicarbonate Supplementation
Authors: MIDDLEBROOK, IndiaPEACOCK, JoeTINNION, Daniel J.LEACH, Nicholas K.HILTON, Nathan P.SAUNDERS, BryanSPARKS, S. AndyNAUGHTON, Lars R. Mc
Citation: FRONTIERS IN NUTRITION, v.8, article ID 634465, 8p, 2021
Abstract: Introduction: Sodium bicarbonate (NaHCO3) is a well-established nutritional ergogenic aid that is typically ingested as a beverage or consumed in gelatine capsules. While capsules may delay the release of NaHCO3 and reduce gastrointestinal (GI) side effects compared with a beverage, it is currently unclear whether the capsule size may influence acid-base responses and GI symptoms following supplementation. Aim: This study aims to determine the effects of NaHCO3 supplementation, administered in capsules of different sizes, on acid-base responses, GI symptoms, and palatability. Methods: Ten healthy male subjects (mean +/- SD: age 20 +/- 2 years; height 1.80 +/- 0.09 m; weight 78.0 +/- 11.9 kg) underwent three testing sessions whereby 0.3 g NaHCO3/kg of body mass was consumed in either small (size 3), medium (size 0), or large (size 000) capsules. Capillary blood samples were procured pre-ingestion and every 10 min post-ingestion for 180 min. Blood samples were analyzed using a radiometer (Radiometer ABL800, Denmark) to determine blood bicarbonate concentration ([HCO3-]) and potential hydrogen (pH). GI symptoms were measured using a questionnaire at the same timepoints, whereas palatability was recorded pre-consumption. Results: Capsule size had a significant effect on lag time (the time [HCO3-] changed, T-lag) and the timing of peak blood [HCO3-] (T-max). Bicarbonate T-lag was significantly higher in the large-sized (28 +/- 4 min) compared with the small-sized (13 +/- 2 min) capsules (P = 0.009). Similarly, T-max was significantly lower in the small capsule (94 +/- 24 min) compared with both the medium-sized (141 +/- 27 min; P < 0.001) and the large-sized (121 +/- 29 min; P < 0.001) capsules. The GI symptom scores were similar for small-sized (3 +/- 3 AU), medium-sized (5 +/- 3 AU), and large-sized (3 +/- 3 AU) capsules, with no significant difference between symptom scores (F = 1.3, P = 0.310). Similarly, capsule size had no effect on palatability (F = 0.8, P = 0.409), with similar scores between different capsule sizes. Conclusion: Small capsule sizes led to quicker T-lag and T-max of blood [HCO3-] concentration compared to medium and large capsules, suggesting that individuals could supplement NaHCO3 in smaller capsules if they aim to increase extracellular buffering capacity more quickly.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/Outros
Outros departamentos - FM/Outros

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia


Files in This Item:
File Description SizeFormat 
art_MIDDLEBROOK_Capsule_Size_Alters_the_Timing_of_Metabolic_Alkalosis_2021.PDFpublishedVersion (English)785.98 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.